Genome Review

Regional Breakdown

The European operator profile fits naturally. UK, Ireland, Malta, Cyprus, Estonia, Bulgaria and Curacao-licensed companies with an EU operating presence all integrate cleanly. SEPA Instant settles across Eurozone banks in 10 seconds, the same headline number every SEPA-Instant participant cites. SWIFT handles GBP and USD international corridors but at standard SWIFT pricing, which is not where Genome competes. Non-EEA residents who want a personal account pay €20/month versus zero for EEA holders, a structural pricing signal that the product is built for Europe first.

Verticals

iGaming is the marketed focus: Genome attends SiGMA Europe, iGB Affiliate, ICE Barcelona and i-Con Limassol annually and publishes iGaming-tagged blog content monthly. Forex brokers and affiliate-marketing networks are the next two priority verticals. eCommerce and transportation receive support but aren't the primary positioning. Genome's high-risk pricing track signals openness to verticals mainstream EU banks reject (gambling, adult, forex, affiliate, certain CBD/nutraceutical categories), but each application goes through individual KYB compliance review.

• iGaming
• Forex
• Affiliate marketing
• eCommerce
• Crypto-adjacent businesses
• Transportation

Deposits via Open Banking are instant; card deposits arrive once the announced acquiring rail goes live (still 'Coming soon' as of June 2026). SEPA Instant payouts clear in under 10 seconds inside the Eurozone, day or night. SEPA Credit payouts settle the next business day. Card processing is slated for T+1 settlement to the merchant business account in EUR, USD or GBP at launch. SWIFT transfers run a standard 1-3 business days depending on corridor. Refunds on the future card rail will follow the standard card-scheme timeline of 5-10 business days, slower than AstroPay (1-3 days) and significantly slower than Brite or Trustly (instant refunds). For SEPA-zone player payouts, Genome's speed profile is strong, comparable to dedicated Open Banking specialists. For FX-corridor settlement, it is standard PSP timing with no particular advantage.

Integration Assessment

A single REST API at developers.genome.eu covering pay-ins, payouts and webhook subscriptions. HmacSHA256 webhook signatures with exponential-backoff retry and an attemptMax counter, so the webhooks are well-engineered. A sandbox environment with test card numbers and test SEPA flows is available before going live. A Hosted Payment Page ("Host-to-Host") lets Genome handle the PCI scope and the checkout look-and-feel. No public GitHub organization. No open-source SDKs, helper libraries, or example apps, which is atypical for a 2026 EU PSP. No CMS plugins (no WooCommerce, no Magento, no Shopify). No pre-built iGaming platform connectors. Documentation quality is Good, with clear endpoint references and webhook examples, but you build everything against the raw API.

Compliance Context

PCI DSS compliance with full card tokenization planned for the acquiring rail (announced, not yet live), so merchants would integrate without entering the PCI Level 1 audit scope. PSD2-compliant Open Banking with SCA on the pay-by-bank flow. GDPR-aligned data residency in the EU. ISO 27001 and ISO 27701 certified. DORA operational-resilience compliance as of the EU rollout. Open Banking runs Strong Customer Authentication today; the card rail is slated for 3DS2 once live. Fraud detection is a combination of internal rules, transaction risk scoring and sanctions screening. Genome has not published a third-party fraud vendor (no Sift, Riskified, Forter, Ravelin) and there is no documented machine-learning model for adaptive risk scoring on cards.

Regulatory Position

Electronic Money Institution licensed by the Bank of Lithuania since 2018. Lithuanian EMI passporting covers all EEA member states. PCI DSS compliant for card processing. PSD2 implementing Open Banking. GDPR data-residency aligned. DORA operational-resilience compliant. There is no standalone gambling regulator license, since Genome is a payments licensee rather than a gambling supplier, so MGA, UKGC and Curacao operator licenses sit on the operator side. Chargeback liability lands on the merchant under standard card-scheme terms, with 3DS2 SCA shifting liability to the issuer on authenticated transactions.

Review Analysis

3.4/5 Trustpilot from 282 reviews. The headline average masks a brutally polarized distribution (early-2026 snapshot: 52% 5-star and 41% 1-star) with very little in the middle. Positive reviews praise the clear web UI, the iOS and Android consumer apps, fast SEPA Instant transfers, and customer support that answers within minutes on routine questions. Negative reviews, and there are a lot of them, cluster on three themes: incoming transfers frozen during AML review with vague terms cited, account closures after long verification cycles with documentation requests that users perceive as endless, and money held for over a month with slow responses from compliance. The pattern is consistent with the structural friction of running high-risk merchant compliance from a single Lithuanian EMI shell: when AML triggers fire, the customer experience drops off a cliff.

Context for Operators

Two structural factors matter when reading the Trustpilot score. First, Genome's review base is mostly consumer-side IBAN users rather than B2B merchant operators, so the score reflects the personal-account experience more than the merchant experience. Second, the 41% 1-star tail is unusual but not unprecedented for EMIs serving high-risk verticals. Wise has had similar polarized periods, and Revolut has had worse. The Lithuanian EMI category as a whole carries this reputation risk because the regulator (the Bank of Lithuania) is stricter on AML triggers than the marketing suggests, and customers experience that friction as the EMI's fault rather than the regulator's. Operators evaluating Genome for merchant acquiring should weight Trustpilot less than peer references inside the iGaming compliance community.

Client Evidence

Genome does not publicly disclose specific iGaming operator clients. The Trustpilot review base (282 reviews) skews toward consumer personal-account users rather than B2B merchant operators, which leaves the B2B reputation hard to read. Conference photography from SiGMA and iGB suggests an active mid-market iGaming merchant pipeline. The structural client profile is European operators that don't qualify for tier-1 enterprise PSPs and want a Bank of Lithuania-regulated shell as the operational layer.